New drug combo tested for Tough-to-Treat sarcoma
NCT ID NCT02805725
Summary
This study tested whether combining two existing cancer drugs (trabectedin and cyclophosphamide) could help control advanced soft-tissue sarcoma in patients whose previous treatments had stopped working. The first phase determined the safest dose, and the second phase checked if the combination could stop cancer growth for at least six months. Fifty patients with advanced, previously treated sarcoma participated in this French-led trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Bergonié
Bordeaux, 33076, France
Conditions
Explore the condition pages connected to this study.